Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya

Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya

Summary: Background: In 2009, Gavi, the World Bank, and donors launched the pneumococcal Advance Market Commitment, which helped countries access more affordable pneumococcal vaccines. As many low-income countries begin to reach the threshold at which countries transition from Gavi support to self-...

Full description

Bibliographic Details
Main Authors: John Ojal, PhD, Ulla Griffiths, PhD, Laura L Hammitt, MD, Ifedayo Adetifa, PhD, Donald Akech, BSc, Collins Tabu, PhD, J Anthony G Scott, FRCP, Stefan Flasche, PhD
Format: Article
Language:English
Published: Elsevier 2019-05-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X1830562X

Similar Items

Similar Items